Central serous chorioretinopathy (CSC);Chorioretinopathia centralis serosa (CCS)

Ophthalmologe

Volumn 107, Issue 5, 2010, Pages 479-493

  Baraki, H ^a   Feltgen, N ^a   Roider, J ^b   Hoerauf, H ^a   Klatt, C ^b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Central serous chorioretinopathy; Central serous retinopathy; Retinal pigment epithelium; Selective retinal therapy; Therapeutic escalation scheme

Indexed keywords

ARTICLE; CENTRAL SEROUS RETINOPATHY; HUMAN;

CENTRAL SEROUS CHORIORETINOPATHY; HUMANS;

EID: 77952428325     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-010-2154-3     Document Type: Article

References (88)

1. Avci R, Deutman AF (1993) Treatment of central serous choroidopathy with the beta receptor blocker metoprolol (preliminary results). Klin Monatsbl Augenheilkd 202: 199-205.
2. Bahrke U, Krause A, Walliser U et al (2000) Retinopathia centralis serosa - Magengeschwür der Augenheilkunde? Psychother Psychosom Med Psychol 50: 464-469.
3. Bandello F, Incorvaia C, Parmeggiani F et al (2000) Idiopathic multiple serous detachments of the retinal pigment epithelium followed by bilateral central serous chorioretinopathy: a case report. Ophthalmologica 214: 362-367.
4. Bandello F, Virgili G, Lanzetta P et al (2001) ICG et decompensation de l'epithelium pigmente retinien (CRSC et epitheliopathies). J Fr Ophtalmol 24: 448-451.
5. Bennett G (1955) Central serous retinopathy. Br J Ophthalmol 39: 605-618.
6. Bouzas EA, Karadimas P, Pournaras CJ (2002) Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 47: 431-448.
7. Brancato R, Scialdone A, Pece A et al (1987) Eight-year follow-up of central serous chorioretinopathy with and without laser treatment. Graefes Arch Clin Exp Ophthalmol 225: 166-168.
8. Brinkmann R, Schule G, Neumann J et al (2006) Selektive Retinatherapie: Methodik, Technik und Online-Dosimetrie. Ophthalmologe 103: 839-849.
9. Bujarborua D, Chatterjee S, Choudhury A et al (2005) Fluorescein angiographic features of asymptomatic eyes in central serous chorioretinopathy. Retina 25: 422-429.
10. Burumcek E, Mudun A, Karacorlu S et al (1997) Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up. Ophthalmology 104: 616-622.
11. Castro-Correia J, Coutinho MF, Rosas V et al (1992) Long-term follow-up of central serous retinopathy in 150 patients. Doc Ophthalmol 81: 379-386.
12. Chan WM, Lai TY, Lai RY et al (2008) Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 115: 1756-1765.
13. Chan WM, Lai TY, Liu DT et al (2007) Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 143: 977-983.
14. Chan WM, Lam DS, Lai TY et al (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87: 1453-1458.
15. Chen SN, Hwang JF, Tseng LF et al (2008) Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology 115: 2229-2234.
16. Chrapek O, Spackova K, Rehak J (2002) Lecba centralni serozni chorioretinopatie betablokatory. Cesk Slov Oftalmol 58: 382-386.
17. Cohen D, Gaudric A, Coscas G et al (1983) Epitheliopathie retinienne diffuse et chorioretinopathie sereuse centrale. J Fr Ophtalmol 6: 339-349.
18. Conrad R, Bodeewes I, Schilling G et al (2000) Chorioretinopathia centralis serosa und psychische Belastung. Ophthalmologe 97: 527-531.
19. Conrad R, Weber NF, Lehnert M et al (2007) Alexithymia and emotional distress in patients with central serous chorioretinopathy. Psychosomatics 48: 489-495.
20. Dickhoff KV, Hoffren M, Laatikainen L (1989) Les modifications de l'epithelium pigmentaire retinien en rapport avec la retinopathie sereuse centrale. J Fr Ophtalmol 12: 877-881.
21. Dohrmann J, Lommatzsch A, Spital G et al (2001) Die Pathogenese der zentralserösen Chorioretinopathie. Angiographische und elektrophysiologische Verlaufsbeobachtungen. Ophthalmologe 98: 1069-1073.
22. Eandi CM, Ober M, Iranmanesh R et al (2005) Acute central serous chorioretinopathy and fundus autofluorescence. Retina 25: 989-993.
23. Ehrenberg M, Landers M (1985) Central serous chorioretinopathy. In: Fraunfelder F, Roy F (eds) Current ocular therapy. Saunders, Philadelphia, pp 467-468.
24. Elsner H, Porksen E, Klatt C et al (2006) Selective retina therapy in patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 244: 1638-1645.
25. Fabianova J, Porubska M, Cepilova Z (1998) Central serous chorioretinopathy - treatment with beta blockers. Cesk Slov Oftalmol 54: 401-404.
26. Faschinger C, Brunner H (1982) Gesichtsfelduntersuchung mit dem Computer-Perimeter Octopus nach Lasertherapie bei Chorioretinitis centralis serosa (Typ I nach Wessing). Klin Monatsbl Augenheilkd 181: 376-378.
27. Faurschou S, Rosenberg T, Nielsen N (1977) Central serous retinopathy and presenile disciform exudative macular degeneration. Is there an aetiological relationship between these two exudative conditions of the macula? Acta Ophthalmol (Copenh) 55: 515-524.
28. Ficker L, Vafidis G, While A et al (1988) Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol 72: 829-834.
29. Framme C, Roider J, Brinkmann R et al (2008) Grundlagen und klinische Anwendung der Lasertherapie an der Netzhaut. Klin Monatsbl Augenheilkd 225: 259-268.
30. Framme C, Walter A, Gabler B et al (2005) Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy. Acta Ophthalmol Scand 83: 161-167.
31. Gackle HC, Lang GE, Freissler KA et al (1998) Chorioretinopathia centralis serosa. Klinische, fluoreszeinangiographische und demographische Aspekte. Ophthalmologe 95: 529-533.
32. Garg SP, Dada T, Talwar D et al (1997) Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol 81: 962-964.
33. Gass JD (1967) Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol [Suppl] 63: 1-139.
34. Gomolin JE (1989) Choroidal neovascularization and central serous chorioretinopathy. Can J Ophthalmol 24: 20-23.
35. Gonzalez C (1992) Decollements sereux retiniens. Interet de l'acetazolamide. J Fr Ophtalmol 15: 529-536.
36. Graefe A (1866) Über die zentrale rezidivierende Retinitis. Graefes Arch Ophthalmol 12: 211-215.
37. Green RP Jr, Carlson DW, Dieckert JP et al (1988) Central serous chorioretinopathy in U. S. Air Force Aviators: a review. Aviat Space Environ Med 59: 1170-1175.
38. Gupta P, Gupta V, Dogra MR et al (2009) Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy. Int Ophthalmol Jan 30. [Epub ahead of print].
39. Harrington D (1947) Ocular manifestations of psychosomatic disorders. J Am Med Assoc 113: 669-674.
40. Hayashi K, Hasegawa Y, Tokoro T (1986) Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol 9: 37-41.
41. Ie D, Yannuzzi LA, Spaide RF et al (1993) Subretinal exudative deposits in central serous chorioretinopathy. Br J Ophthalmol 77: 349-353.
42. Klatt C, Elsner H, Porksen E et al (2006) Selective retina therapy in central serous chorioretinopathy with detachment of the pigmentary epithelium. Ophthalmologe 103: 850-855.
43. Klein ML, van Buskirk EM, Friedman E et al (1974) Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol 91: 247-250.
44. Klien B (1956) Retinal lesions associated with uveal disease, part 1. Am J Ophthalmol 42: 831-847.
45. Marmor M (1997) On the cause of serous detachments and acute central serous chorioretinopathy. Br J Ophthalmol 81: 812-813.
46. Marmor MF, Maack T (1982) Enhancement of retinal adhesion and subretinal fluid resorption by acetazolamide. Invest Ophthalmol Vis Sci 23: 121-124.
47. Mitarai K, Gomi F, Tano Y (2006) Three-dimensional optical coherence tomographic findings in central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 244: 1415-1420.
48. Naumann G (1997) Zentrale seröse Chorioretinopathie. In: Naumann G (Hrsg) Pathologie des Auges, vol 2. Springer, Berlin Heidelberg New York, S 1088-1089.
49. Newman DG (2002) Central serous retinopathy with permanent visual deficit in a commercial air transport pilot: a case report. Aviat Space Environ Med 73: 1122-1126.
50. Oosterhuis JA (1996) Familial central serous retinopathy. Graefes Arch Clin Exp Ophthalmol 234: 337-341.
51. Park DW, Schatz H, Gaffney MM et al (1998) Central serous chorioretinopathy in two families. Eur J Ophthalmol 8: 42-47.
52. Peyman GA, Bok D (1972) Peroxidase diffusion in the normal and laser-coagulated primate retina. Invest Ophthalmol 11: 35-45.
53. Piccolino FC, Borgia L (1994) Central serous chorioretinopathy and indocyanine green angiography. Retina 14: 231-242.
54. Pikkel J, Beiran I, Ophir A et al (2002) Acetazolamide for central serous retinopathy. Ophthalmology 109: 1723-1725.
55. Pollack JS, Kim JE, Pulido JS et al (1998) Tissue effects of subclinical diode laser treatment of the retina. Arch Ophthalmol 116: 1633-1639.
56. Prunte C (1995) Indocyanine green angiographic findings in central serous chorioretinopathy. Int Ophthalmol 19: 77-82.
57. Prunte C, Flammer J (1996) Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 121: 26-34.
58. Robertson DM, Ilstrup D (1983) Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 95: 457-466.
59. Roider J, Brinkmann R, Wirbelauer C et al (1999) Retinal sparing by selective retinal pigment epithelial photocoagulation. Arch Ophthalmol 117: 1028-1034.
60. Saito M, Iida T, Kishi S (2005) Ring-shaped subretinal fibrinous exudate in central serous chorioretinopathy. Jpn J Ophthalmol 49: 516-519.
61. Schaal KB, Hoeh AE, Scheuerle A et al (2009) Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy. Eur J Ophthalmol 19: 613-617.
62. Schatz H, Madeira D, Johnson RN et al (1992) Central serous chorioretinopathy occurring in patients 60 years of age and older. Ophthalmology 99: 63-67.
63. Schatz H, Yannuzzi LA, Gitter KA (1977) Subretinal neovascularization following argon laser photocoagulation treatment for central serous chorioretinopathy: complication or misdiagnosis? Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 83: 893-906.
64. Schuele G, Rumohr M, Huettmann G et al (2005) RPE damage thresholds and mechanisms for laser exposure in the microsecond-to-millisecond time regimen. Invest Ophthalmol Vis Sci 46: 714-719.
65. Shanmugam MP, Bhende M (2000) Retinal pigment epithelial tears associated with idiopathic central serous chorioretinopathy. Indian J Ophthalmol 48: 315-317.
66. Sharma T, Shah N, Rao M et al (2004) Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy. Ophthalmology 111: 1708-1714.
67. Spahn C, Wiek J, Burger T (2004) Operationalized psychodynamic diagnostics (OPD) in patients with central serous chorioretinopathy. Psychother Psychosom Med Psychol 54: 52-57.
68. Spahn C, Wiek J, Burger T et al (2003) Psychosomatic aspects in patients with central serous chorioretinopathy. Br J Ophthalmol 87: 704-708.
69. Spaide RF, Campeas L, Haas A et al (1996) Central serous chorioretinopathy in younger and older adults. Ophthalmology 103: 2070-2080.
70. Spaide RF, Hall L, Haas A et al (1996) Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 16: 203-213.
71. Spitznas M, Huke J (1987) Number, shape, and topography of leakage points in acute type I central serous retinopathy. Graefes Arch Clin Exp Ophthalmol 225: 437-440.
72. Stoffelns BM, Kramann C, Schoepfer K (2008) Central serous chorioretinopathy (CSC) and corticosteroids. Klin Monatsbl Augenheilkd 225: 370-375.
73. Sun J, Tan J, Wang Z et al (2003) Effect of catecholamine on central serous chorioretinopathy. J Huazhong Univ Sci Technolog Med Sci 23: 313-316.
74. Torres-Soriano ME, Garcia-Aguirre G, Kon-Jara V et al (2008) A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports). Graefes Arch Clin Exp Ophthalmol 246: 1235-1239.
75. Velthoven ME van, Verbraak FD, Garcia PM et al (2005) Evaluation of central serous retinopathy with en face optical coherence tomography. Br J Ophthalmol 89: 1483-1488.
76. Ruckmann A von, Fitzke FW, Fan J et al (2002) Abnormalities of fundus autofluorescence in central serous retinopathy. Am J Ophthalmol 133: 780-786.
77. Wang M, Munch IC, Hasler PW et al (2008) Central serous chorioretinopathy. Acta Ophthalmol 86: 126-145.
78. Wang M, Sander B, Cour M la et al (2005) Clinical characteristics of subretinal deposits in central serous chorioretinopathy. Acta Ophthalmol Scand 83: 691-696.
79. Wang MS, Sander B, Larsen M (2002) Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol 133: 787-793.
80. Watzke RC, Burton TC, Woolson RF (1979) Direct and indirect laser photocoagulation of central serous choroidopathy. Am J Ophthalmol 88: 914-918.
81. Werry H, Arends C (1978) Untersuchung zur Objektivierung von Personlichkeitsmerkmalen bei Patienten mit Retinopathia centralis serosa. Klin Monatsbl Augenheilkd 172: 363-370.
82. Wong R, Chopdar A, Brown M (2004) Five to 15 year follow-up of resolved idiopathic central serous chorioretinopathy. Eye (London, England) 18: 262-268.
83. Yamada K, Hayasaka S, Setogawa T (1992) Fluorescein-angiographic patterns in patients with central serous chorioretinopathy at the initial visit. Ophthalmologica 205: 69-76.
84. Yannuzzi LA (1986) Type A behavior and central serous chorioretinopathy. Trans Am Ophthalmol Soc 84: 799-845.
85. Yannuzzi LA (1987) Type-A behavior and central serous chorioretinopathy. Retina 7: 111-131.
86. Yannuzzi LA, Slakter JS, Gross NE et al (2003) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 23: 288-298.
87. Yoshioka H (1991) The etiology of central serous chorioretinopathy. Nippon Ganka Gakkai Zasshi 95: 1181-1195.
88. Zeligs M (1947) Central angiospastic retinopathy. A psychosomatic study and its occurence in military personnel. Psychosom Med 9: 110-117.